Investors / Spain / Prous Institute for Biomedical Research
Prous Institute for Biomedical Research
Investor · Barcelona, Spain · Europe
Prous Institute for Biomedical Research is a Barcelona-based organization, spun off from Prous Science, that partners with and invests in early-stage life sciences initiatives. It provides seed capital, industry expertise, networking and hands-on support to help research projects reach proof-of-concept.
Invests inHealthcare & Biotech
In its own wordsdata sciencelife sciencesdrug discoverydigital healthmedical technologybiomarkers
Your fit with Prous Institute for Biomedical Research
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsProus Institute for Biomedical Research lists 10 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (90%) and Education (10%). 100% of its companies are based in Spain. It invests most often alongside Asabys Partners, APEX Ventures and Amadeus Capital Partners.
Counts come from funding rounds that name Prous Institute for Biomedical Research, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Prous Institute for Biomedical Research's whole history. Rounds on record name 1 company; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 77th | 10% of companies confirmed by a round |
| Sector focus | 95th | 90% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Asabys Partners | 2 |
| APEX Ventures | 1 |
| Amadeus Capital Partners | 1 |
| Angels Capital | 1 |
| Bronze Valley | 1 |
| Clave | 1 |
| Columbus Venture Partners | 1 |
| LifeLink Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 90% | 15% |
| Education | 10% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Prous Institute for Biomedical Research head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Prous Institute for Biomedical Research| Date | Company | Stage |
|---|---|---|
| 10 Sept 2026 | Seed |
Round details for Prous Institute for Biomedical Research
Amounts, full round histories and every co-investor in Prous Institute for Biomedical Research's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Accure Therapeutics is a R&D pharma company dedicated to developing innovative medicines to treat patients suffering from Central nervous system (CNS) diseases | Healthcare & Biotech | Portfolio page | ||
| Chemotargets collects and learns from the world's biomedical data to advance drug discovery and development. | Healthcare & Biotech | Portfolio page | ||
| Connecta Therapeutics is committed to discovering and developing new treatments to respond to unmet CNS medical needs | Healthcare & Biotech | Sept 2026Seed | Page + round | |
| D-Sight is a company dedicated to the discovery and development of new innovative treatments for neurodegenerative diseases of the retina. | Healthcare & Biotech | Portfolio page | ||
| The company provides infrastructure for post-appointment care, allowing medical practices to check in with patients after their visits | Healthcare & Biotech | Portfolio page | ||
| Kiin reduces behavioural risk at work. | EducationHealthcare & Biotech | Portfolio page | ||
| MedBioinformatics turns biomedical evidence into knowledge and provides solutions such as AI-ready biomedical knowledge systems and databases | Healthcare & Biotech | Portfolio page | ||
| Nanobots Therapeutics is a biotech company focused on developing and commercializing MotionTx platform. | Healthcare & Biotech | Portfolio page | ||
| Quibim designs pioneering tools that unlock imaging data to improve patient outcomes | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- prousresearch.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 10 Sept 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Prous Institute for Biomedical Research's profile as data
Pull Prous Institute for Biomedical Research's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/prousresearch.com
# also
GET /v1/firms/prousresearch.com/portfolio
GET /v1/firms/prousresearch.com/coinvestors
GET /v1/firms/prousresearch.com/news